Cargando…
Targeted RNA-sequencing analysis for fusion transcripts detection in tumor diagnostics: assessment of bioinformatic tools reliability in FFPE samples
AIM: Diagnostic laboratories are progressively introducing next-generation sequencing (NGS) technologies in the routine workflow to meet the increasing clinical need for comprehensive molecular characterization in cancer patients for diagnosis and precision medicine, including fusion-transcripts det...
Autores principales: | Capone, Iolanda, Bozzi, Fabio, Dagrada, Gian Paolo, Verderio, Paolo, Conca, Elena, Busico, Adele, Testi, Maria Adele, Monti, Valentina, Duca, Matteo, Proto, Claudia, Damian, Silvia, Piccolo, Alberta, Perrone, Federica, Tamborini, Elena, Devecchi, Andrea, Collini, Paola, Lorenzini, Daniele, Vingiani, Andrea, Agnelli, Luca, Pruneri, Giancarlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Open Exploration
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630092/ https://www.ncbi.nlm.nih.gov/pubmed/36338518 http://dx.doi.org/10.37349/etat.2022.00102 |
Ejemplares similares
-
Prevalence of BRCA homopolymeric indels in an ION Torrent-based tumour-to-germline testing workflow in high-grade ovarian carcinoma
por: Azzollini, Jacopo, et al.
Publicado: (2023) -
Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model
por: Azzollini, Jacopo, et al.
Publicado: (2022) -
Molecular Tumor Board as a Clinical Tool for Converting Molecular Data Into Real-World Patient Care
por: Vingiani, Andrea, et al.
Publicado: (2023) -
A2AR Expression and Immunosuppressive Environment Independent of KRAS and GNAS Mutations in Pseudomyxoma Peritonei
por: Kusamura, Shigeki, et al.
Publicado: (2023) -
Molecular Signatures for Combined Targeted Treatments in Diffuse Malignant Peritoneal Mesothelioma
por: Belfiore, Antonino, et al.
Publicado: (2019)